Norovirus-Like Particles
To support norovirus research and development, The Native Antigen Company offers an extended range of 8 norovirus-like particles, produced from their proprietary VirtuE™ (HEK293) and insect-baculovirus expression systems.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The Native Antigen Companies norovirus VLPs are comprised of VP1 proteins, that self-assemble as an icosahedron of 180 subunits. VP1 is a 59kDa glycoprotein with three key domains: The shell domain (S domain) contains elements essential for the formation of the icosahedron. The Protruding domain (P domain) is divided into sub-domains P1 and P2. The P domain interacts in dimeric contacts that increase the stability of the capsid and form the protrusions on the virion. A hypervariable region in P2 is thought to play an important role in receptor binding and immune reactivity.
The VLPs are non-infectious and safe to use, while displaying native-like epitopes and glycosylation patterns. A study by Metz and colleagues, for example, showed that the VirtuE™-expressed dengue VLPs exhibit comparable epitopes to native viral particles. VLPs are suitable for a wide range of applications, including the development of in vitro diagnostic assays and vaccines. The highly repetitive structural patterns presented by VLPs also makes them ideal antigens for raising high-avidity antibodies.
